Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (45)
Elizabeth J. Klein, Christina S. Oh, Maria Karim, Jerry Shapiro & Kristen Lo Sicco. (2023) A practical approach to the management of hair loss in patients with polycystic ovary syndrome. Journal of the European Academy of Dermatology and Venereology 37:8, pages 1480-1489.
Crossref
Crossref
Fernando Bril, Uche Ezeh, Mina Amiri, Sana Hatoum, Lauren Pace, Yen-Hao Chen, Fred Bertrand, Barbara Gower & Ricardo Azziz. (2023) Adipose Tissue Dysfunction in Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism.
Crossref
Crossref
C. Arman, K. Balci, Y. Akkaya, S. Akyuz, T. Reaves-Mckee, A.H. Frankamp, J.T. Coates, W.B. Collier, G. Ritzhaupt, C.E. Klehm & P. Desman. (2023) The effects of conformation and intermolecular hydrogen bonding on the structure and IR spectra of flutamide; a study based on the matrix isolation technique, ab initio and DFT calculations. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 292, pages 122417.
Crossref
Crossref
Akansha Bisht, Ritika Gururani, Smita Jain, Rahul Shukla, Jaya Dwivedi & Swapnil Sharma. (2023) Cedrus deodara (Roxb. ex D.Don) G.Don bark fraction ameliorates metabolic, endocrine and ovarian dynamics in rats experiencing polycystic ovarian syndrome. Journal of Ethnopharmacology 306, pages 116206.
Crossref
Crossref
Viktor V. Smirnov, Narasimha M. Beeraka, Dmitry Yu Butko, Vladimir N. Nikolenko, Sergey A. Bondarev, Evgeniy E. Achkasov, Mikhail Y. Sinelnikov & P. R. Hemanth Vikram. (2022) Updates on Molecular Targets and Epigenetic-Based Therapies for PCOS. Reproductive Sciences 30:3, pages 772-786.
Crossref
Crossref
Samradhi Singh, Namrata Pal, Swasti Shubham, Devojit Kumar Sarma, Vinod Verma, Francesco Marotta & Manoj Kumar. (2023) Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics. Journal of Clinical Medicine 12:4, pages 1454.
Crossref
Crossref
Ge Xu, Xuedan Zhao, Zhihao Li, Junwei Hu, Xu Li, Juanjuan Li & Yuelai Chen. (2023) Effects of electroacupuncture on the kisspeptin-gonadotropin-releasing hormone (GnRH) /luteinizing hormone (LH) neural circuit abnormalities and androgen receptor expression of kisspeptin/neurokinin B/dynorphin neurons in PCOS rats. Journal of Ovarian Research 16:1.
Crossref
Crossref
Daniel A. Dumesic, Chloe Winnett, Gwyneth Lu, Tristan R. Grogan, David H. Abbott, Rajanigandha Naik & Gregorio D. Chazenbalk. (2023) Randomized clinical trial: effect of low-dose flutamide on abdominal adipogenic function in normal-weight women with polycystic ovary syndrome. Fertility and Sterility 119:1, pages 116-126.
Crossref
Crossref
Kirsty A Walters, Alba Moreno-Asso, Nigel K Stepto, Michael W Pankhurst, Valentina Rodriguez Paris & Raymond J Rodgers. (2022) Key signalling pathways underlying the aetiology of polycystic ovary syndrome. Journal of Endocrinology 255:1, pages R1-R26.
Crossref
Crossref
Sambit Roy, Aierken Abudu, Irving Salinas, Niharika Sinha, Holly Cline-Fedewa, Alexandra M Yaw, Wenjie Qi, Todd A Lydic, Diana L Takahashi, Jon D Hennebold, Hanne M Hoffmann, Jianrong Wang & Aritro Sen. (2022) Androgen-mediated Perturbation of the Hepatic Circadian System Through Epigenetic Modulation Promotes NAFLD in PCOS Mice. Endocrinology 163:10.
Crossref
Crossref
Tabatha Petrillo, Elisa Semprini, Veronica Tomatis, Melania Arnesano, Fedora Ambrosetti, Christian Battipaglia, Alessandra Sponzilli, Francesco Ricciardiello, Andrea R. Genazzani & Alessandro D. Genazzani. (2022) Putative Complementary Compounds to Counteract Insulin-Resistance in PCOS Patients. Biomedicines 10:8, pages 1924.
Crossref
Crossref
Akanksha Garg, Bijal Patel, Ali Abbara & Waljit S. Dhillo. (2022) Treatments targeting neuroendocrine dysfunction in polycystic ovary syndrome (PCOS). Clinical Endocrinology 97:2, pages 156-164.
Crossref
Crossref
Fazilah Abdul Hamid, Muhammad Azrai Abu, Abdul Kadir Abdul Karim, Mohd Faizal Ahmad, Nor Haslinda Abd. Aziz, Datu Agasi Mohd Kamal & Mohd Helmy Mokhtar. (2022) Sex Steroid Receptors in Polycystic Ovary Syndrome and Endometriosis: Insights from Laboratory Studies to Clinical Trials. Biomedicines 10:7, pages 1705.
Crossref
Crossref
Mauro S.B. Silva & Rebecca E. Campbell. 2011. Comprehensive Physiology. Comprehensive Physiology
3347
3369
.
Rao Zhou, Cristin M. Bruns, Ian M. Bird, Joseph W. Kemnitz, Daniel A. Dumesic & David H. Abbott. (2022) Experimentally Induced Hyperinsulinemia Fails to Induce Polycystic Ovary Syndrome-like Traits in Female Rhesus Macaques. International Journal of Molecular Sciences 23:5, pages 2635.
Crossref
Crossref
Christopher R. McCartney, Rebecca E. Campbell, John C. Marshall & Suzanne M. Moenter. (2022) The role of gonadotropin‐releasing hormone neurons in polycystic ovary syndrome. Journal of Neuroendocrinology.
Crossref
Crossref
Duarte Pignatelli, Sofia S. Pereira & Eleni Kandaraki. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
55
71
.
Emmi Rotgers, Barbara Nicol, Karina Rodriguez, Saniya Rattan, Jodi A. Flaws & Humphrey Hung‐Chang Yao. (2021) Constitutive expression of Steroidogenic factor‐1 (NR5A1) disrupts ovarian functions, fertility, and metabolic homeostasis in female mice. The FASEB Journal 35:8.
Crossref
Crossref
Si-wei Zhang, Jing Zhou, Hans-Jürgen Gober, Wing Ting Leung & Ling Wang. (2021) Effect and mechanism of berberine against polycystic ovary syndrome. Biomedicine & Pharmacotherapy 138, pages 111468.
Crossref
Crossref
Irene E Sucquart, Ruchi Nagarkar, Melissa C Edwards, Valentina Rodriguez Paris, Ali Aflatounian, Michael J Bertoldo, Rebecca E Campbell, Robert B Gilchrist, Denovan P Begg, David J Handelsman, Vasantha Padmanabhan, Richard A Anderson & Kirsty A Walters. (2021) Neurokinin 3 Receptor Antagonism Ameliorates Key Metabolic Features in a Hyperandrogenic PCOS Mouse Model. Endocrinology 162:5.
Crossref
Crossref
E Elenis, E Desroziers, S Persson, I Sundström Poromaa & R E Campbell. (2021) Early initiation of anti-androgen treatment is associated with increased probability of spontaneous conception leading to childbirth in women with polycystic ovary syndrome: a population-based multiregistry cohort study in Sweden. Human Reproduction 36:5, pages 1427-1435.
Crossref
Crossref
Haiming Yu, Xiaoqing Zhou, Yujing Zhang, Kexin Wen, Zhengli Yan, Hu Fu & Yongfei Zhu. (2021) Flutamide induces uterus and ovary damage in the mouse via apoptosis and excessive autophagy of cells following triggering of the unfolded protein response. Reproduction, Fertility and Development 33:7, pages 466-475.
Crossref
Crossref
Jacky K. Leung, Amy H. Tien & Marianne D. Sadar. 2021. Nuclear Receptors. Nuclear Receptors
411
461
.
Alessandro D. Genazzani, Ambrosetti Fedora, Despini Giulia, Manzo Alba, Caroli Martina, Arnesano Melania, Petrillo Tabatha, Tomatis Veronica & Andrea R. Genazzani. 2021. Impact of Polycystic Ovary, Metabolic Syndrome and Obesity on Women Health. Impact of Polycystic Ovary, Metabolic Syndrome and Obesity on Women Health
67
74
.
David H Abbott, Jon E Levine & Daniel A Dumesic. (2020) Androgen Receptors in Multiple Organ Systems Provide Molecular Gateways to Polycystic Ovary Syndrome. Endocrinology 161:8.
Crossref
Crossref
Madeleine J Cox, Melissa C Edwards, Valentina Rodriguez Paris, Ali Aflatounian, William L Ledger, Robert B Gilchrist, Vasantha Padmanabhan, David J Handelsman & Kirsty A Walters. (2020) Androgen Action in Adipose Tissue and the Brain are Key Mediators in the Development of PCOS Traits in a Mouse Model. Endocrinology 161:7.
Crossref
Crossref
Yong Wook Jung, Gun Ho Lee, You Jung Han & Dong Hyun Cha. (2020) Insight into the pathogensis of polycystic ovarian syndrome. Journal of Genetic Medicine 17:1, pages 1-10.
Crossref
Crossref
Yufeng He, Qianqian Wang, Xiu Li, Gang Wang, Jianxin Zhao, Hao Zhang & Wei Chen. (2020) Lactic acid bacteria alleviate polycystic ovarian syndrome by regulating sex hormone related gut microbiota. Food & Function 11:6, pages 5192-5204.
Crossref
Crossref
Kirsty A. Walters. (2020) Polycystic ovary syndrome: Is it androgen or estrogen receptor?. Current Opinion in Endocrine and Metabolic Research 12, pages 1-7.
Crossref
Crossref
Mariagrazia StracquadanioMariagrazia Stracquadanio. 2020. Managing Women’s Hyperandrogenism. Managing Women’s Hyperandrogenism
35
83
.
Amy Ruddenklau & Rebecca E Campbell. (2019) Neuroendocrine Impairments of Polycystic Ovary Syndrome. Endocrinology 160:10, pages 2230-2242.
Crossref
Crossref
Valentina Rodriguez Paris & Michael J. Bertoldo. (2019) The Mechanism of Androgen Actions in PCOS Etiology. Medical Sciences 7:9, pages 89.
Crossref
Crossref
Diane M Duffy, CheMyong Ko, Misung Jo, Mats Brannstrom & Thomas E CurryJr.Jr.. (2019) Ovulation: Parallels With Inflammatory Processes. Endocrine Reviews 40:2, pages 369-416.
Crossref
Crossref
M. Kupreeva, A. Diane, R. Lehner, R. Watts, M. Ghosh, S. Proctor & D. Vine. (2019) Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model. American Journal of Physiology-Endocrinology and Metabolism 316:1, pages E16-E33.
Crossref
Crossref
Li-Feng Sun, Ya-Li Yang, Tian-Xia Xiao, Meng-Xia Li & Jian V. Zhang. (2019) Removal of DHT can relieve polycystic ovarian but not metabolic abnormalities in DHT-induced hyperandrogenism in mice. Reproduction, Fertility and Development 31:10, pages 1597.
Crossref
Crossref
Kirsty A. Walters, Robert B. Gilchrist, William L. Ledger, Helena J. Teede, David J. Handelsman & Rebecca E. Campbell. (2018) New Perspectives on the Pathogenesis of PCOS: Neuroendocrine Origins. Trends in Endocrinology & Metabolism 29:12, pages 841-852.
Crossref
Crossref
K.A. Walters, M.J. Bertoldo & D.J. Handelsman. (2018) Evidence from animal models on the pathogenesis of PCOS. Best Practice & Research Clinical Endocrinology & Metabolism 32:3, pages 271-281.
Crossref
Crossref
Genevieve E Ryan, Shaddy Malik & Pamela L Mellon. (2018) Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS. Endocrinology 159:4, pages 1734-1747.
Crossref
Crossref
Ricardo Azziz. (2017) Animal models for PCOS — not the real thing. Nature Reviews Endocrinology 13:7, pages 382-384.
Crossref
Crossref
Aimee S. L. CaldwellMelissa C. Edwards, Reena DesaiMark JimenezRobert B. Gilchrist, David J. Handelsman & Kirsty A. Walters. (2017) Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome. Proceedings of the National Academy of Sciences 114:16.
Crossref
Crossref
Kirsty A. Walters. (2016) Androgens in polycystic ovary syndrome. Current Opinion in Endocrinology, Diabetes & Obesity 23:3, pages 257-263.
Crossref
Crossref
K A Walters. (2015) Role of androgens in normal and pathological ovarian function. REPRODUCTION 149:4, pages R193-R218.
Crossref
Crossref
Wendy Vitek, Snigdha Alur & Kathleen M. Hoeger. (2015) Off-label drug use in the treatment of polycystic ovary syndrome. Fertility and Sterility 103:3, pages 605-611.
Crossref
Crossref
Andrea R. Genazzani & Alessandro D. Genazzani. 2015. Frontiers in Gynecological Endocrinology. Frontiers in Gynecological Endocrinology
25
31
.
Harpreet Bhatia, Anupama Kumar, Yukiko Ogino, Jun Du, Adrienne Gregg, John Chapman, Mike J. McLaughlin & Taisen Iguchi. (2014)
Effects of the commercial antiandrogen flutamide on the biomarkers of reproduction in male Murray rainbowfish (
Melanotaenia fluviatilis
)
. Environmental Toxicology and Chemistry 33:5, pages 1098-1107.
Crossref
Crossref